BackSanara MedTech Overview

Sanara MedTech Receivables

Track Sanara MedTech's receivables ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$13.62M
14.80% YoYΔ $1.76M vs prior year quarter

Peer average

Loading

Sanara MedTech Receivables History

Loading

Sanara MedTech vs. peers: Receivables Comparison

Loading

Sanara MedTech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sanara MedTech (SMTI) FAQ

As of the most recent data (March 2026), SMTI shows a receivables of $14M. That compares with $12M in the prior-year period — up 14.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SMTI's receivables is now $14M (was $12M) — a 14.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sanara MedTech is outperforming or lagging.

Tracking SMTI's receivables over time shows whether Sanara MedTech is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $12M in the prior-year period — up 14.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Sanara MedTech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $14M) with ownership activity and broader fundamentals.

Sanara MedTech's receivables is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.